Treatment of depression in HIV-infected patients

Carlo L. Cazzullo, Enrico Bessone, Paolo Bertrando, Laura Pedrazzoli, Marco Cusini

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Pharmacological treatment of depression in HIV-infected patients has been found to be effective. This study assessed the efficacy and feasibility of treatment with fluoxetine and the best method of administering the drug to patients with HIV infection. Methods: Sixteen seropositive and 16 seronegative patients, equally matched for age and sex, who had Hamilton Rating Scale for Depression scores of at least 16 and who received at least 20 mg/d of fluoxetine for 8 weeks were studied. Results: Depression was alleviated in both groups. However, improvement in the seropositive patients occurred later. Interpretation: The results confirm the effectiveness of fluoxetine in treating depression in people with HIV infection. The lack of adverse effects makes this treatment particularly suitable, especially because seronegative people take longer to respond to treatment.

Original languageEnglish
Pages (from-to)293-297
Number of pages5
JournalJournal of Psychiatry and Neuroscience
Volume23
Issue number5
Publication statusPublished - 1998

Fingerprint

Fluoxetine
HIV
HIV Infections
Therapeutics
Pharmacology
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Cazzullo, C. L., Bessone, E., Bertrando, P., Pedrazzoli, L., & Cusini, M. (1998). Treatment of depression in HIV-infected patients. Journal of Psychiatry and Neuroscience, 23(5), 293-297.

Treatment of depression in HIV-infected patients. / Cazzullo, Carlo L.; Bessone, Enrico; Bertrando, Paolo; Pedrazzoli, Laura; Cusini, Marco.

In: Journal of Psychiatry and Neuroscience, Vol. 23, No. 5, 1998, p. 293-297.

Research output: Contribution to journalArticle

Cazzullo, CL, Bessone, E, Bertrando, P, Pedrazzoli, L & Cusini, M 1998, 'Treatment of depression in HIV-infected patients', Journal of Psychiatry and Neuroscience, vol. 23, no. 5, pp. 293-297.
Cazzullo CL, Bessone E, Bertrando P, Pedrazzoli L, Cusini M. Treatment of depression in HIV-infected patients. Journal of Psychiatry and Neuroscience. 1998;23(5):293-297.
Cazzullo, Carlo L. ; Bessone, Enrico ; Bertrando, Paolo ; Pedrazzoli, Laura ; Cusini, Marco. / Treatment of depression in HIV-infected patients. In: Journal of Psychiatry and Neuroscience. 1998 ; Vol. 23, No. 5. pp. 293-297.
@article{fbcb5409b5144743a7602357645377ad,
title = "Treatment of depression in HIV-infected patients",
abstract = "Background: Pharmacological treatment of depression in HIV-infected patients has been found to be effective. This study assessed the efficacy and feasibility of treatment with fluoxetine and the best method of administering the drug to patients with HIV infection. Methods: Sixteen seropositive and 16 seronegative patients, equally matched for age and sex, who had Hamilton Rating Scale for Depression scores of at least 16 and who received at least 20 mg/d of fluoxetine for 8 weeks were studied. Results: Depression was alleviated in both groups. However, improvement in the seropositive patients occurred later. Interpretation: The results confirm the effectiveness of fluoxetine in treating depression in people with HIV infection. The lack of adverse effects makes this treatment particularly suitable, especially because seronegative people take longer to respond to treatment.",
author = "Cazzullo, {Carlo L.} and Enrico Bessone and Paolo Bertrando and Laura Pedrazzoli and Marco Cusini",
year = "1998",
language = "English",
volume = "23",
pages = "293--297",
journal = "Journal of Psychiatry and Neuroscience",
issn = "1180-4882",
publisher = "Canadian Medical Association",
number = "5",

}

TY - JOUR

T1 - Treatment of depression in HIV-infected patients

AU - Cazzullo, Carlo L.

AU - Bessone, Enrico

AU - Bertrando, Paolo

AU - Pedrazzoli, Laura

AU - Cusini, Marco

PY - 1998

Y1 - 1998

N2 - Background: Pharmacological treatment of depression in HIV-infected patients has been found to be effective. This study assessed the efficacy and feasibility of treatment with fluoxetine and the best method of administering the drug to patients with HIV infection. Methods: Sixteen seropositive and 16 seronegative patients, equally matched for age and sex, who had Hamilton Rating Scale for Depression scores of at least 16 and who received at least 20 mg/d of fluoxetine for 8 weeks were studied. Results: Depression was alleviated in both groups. However, improvement in the seropositive patients occurred later. Interpretation: The results confirm the effectiveness of fluoxetine in treating depression in people with HIV infection. The lack of adverse effects makes this treatment particularly suitable, especially because seronegative people take longer to respond to treatment.

AB - Background: Pharmacological treatment of depression in HIV-infected patients has been found to be effective. This study assessed the efficacy and feasibility of treatment with fluoxetine and the best method of administering the drug to patients with HIV infection. Methods: Sixteen seropositive and 16 seronegative patients, equally matched for age and sex, who had Hamilton Rating Scale for Depression scores of at least 16 and who received at least 20 mg/d of fluoxetine for 8 weeks were studied. Results: Depression was alleviated in both groups. However, improvement in the seropositive patients occurred later. Interpretation: The results confirm the effectiveness of fluoxetine in treating depression in people with HIV infection. The lack of adverse effects makes this treatment particularly suitable, especially because seronegative people take longer to respond to treatment.

UR - http://www.scopus.com/inward/record.url?scp=0032438358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032438358&partnerID=8YFLogxK

M3 - Article

C2 - 9846034

AN - SCOPUS:0032438358

VL - 23

SP - 293

EP - 297

JO - Journal of Psychiatry and Neuroscience

JF - Journal of Psychiatry and Neuroscience

SN - 1180-4882

IS - 5

ER -